| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8341067 | Microvascular Research | 2016 | 9 Pages |
Abstract
Taken together, we show that monomethyl fumarate, the primary metabolite of dimethyl fumarate, which is currently used in the clinics for the treatment of relapsing-remitting multiple sclerosis, demonstrates beneficial therapeutic effects at the inflamed blood-brain barrier.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Jamie L. Lim, Susanne M.A. van der Pol, Flaminia Di Dio, Bert van het Hof, Gijs Kooij, Helga E. de Vries, Jack van Horssen,